Correlation Between Reviva Pharmaceuticals and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Bone Biologics Corp, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Bone Biologics.

Diversification Opportunities for Reviva Pharmaceuticals and Bone Biologics

-0.86

Correlation Coefficient

Reviva Pharmaceuticals  Bone Biologics

Pay attention - limited upside

The 3 months correlation between Reviva and Bone is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Bone Biologics go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Bone Biologics

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to under-perform the Bone Biologics. In addition to that, Reviva Pharmaceuticals is 1.13 times more volatile than Bone Biologics Corp. It trades about -0.07 of its total potential returns per unit of risk. Bone Biologics Corp is currently generating about 0.15 per unit of volatility. If you would invest  2,064  in Bone Biologics Corp on March 13, 2024 and sell it today you would earn a total of  2,098  from holding Bone Biologics Corp or generate 101.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Bone Biologics Corp

Reviva Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in July 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Bone Biologics Corp

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Reviva Pharmaceuticals and Bone Biologics

The main advantage of trading using opposite Reviva Pharmaceuticals and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Reviva Pharmaceuticals Holdings and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.